Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/43703
Title: Levels of ADAM10 are reduced in Alzheimer's disease CSF.
Authors: 
Mesh: 
Issue Date: 25-Jul-2018
Citation: J Neuroinflammation.2018 Jul;(15)1:213
Abstract: The disintegrin metalloproteinase 10 (ADAM10) is the main α-secretase acting in the non-amyloidogenic processing of the amyloid precursor protein. This study assesses whether ADAM10 is present in cerebrospinal fluid (CSF), and whether it has potential as a biomarker for Alzheimer's disease (AD).
PMID: 30045733
URI: https://hdl.handle.net/20.500.12530/43703
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC6060469.pdf919.32 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.